Related Experiment Videos
[Severe late-onset group B streptococcal infection. A case report]
Roland Haase1, Frank Nagel, Wolfgang Hirsch
1Zentrum für Kinderheilkunde, Universitätsklinik und Poliklinik für Kinder- und Jugendmedizin, Martin-Luther-Universität Halle-Wittenberg. roland.haase@medizin.uni-halle.de
Zeitschrift Fur Geburtshilfe Und Neonatologie
|November 6, 2003
Summary
Late-onset Group B Streptococcus (GBS) meningitis in infants remains a challenge, as current antibiotic prophylaxis is ineffective. Maternal vaccination offers a promising new strategy for infant protection against GBS infections.
Area of Science:
- Neonatal infectious diseases
- Bacterial meningitis
- Public health
Background:
- Group B Streptococcus (GBS) causes significant neonatal infections like pneumonia, sepsis, and meningitis.
- Peripartal antibiotic prophylaxis is standard for early-onset GBS but ineffective for late-onset disease.
- Late-onset GBS meningitis carries a high risk of severe neurological sequelae in infants.
Observation:
- A 3-week-old infant developed GBS meningitis with necrotizing encephalomalacia shortly after hospital discharge.
- The infant's mother had mastitis, but maternal GBS cultures were negative, suggesting a nosocomial infection.
- This case highlights the limitations of current GBS prevention strategies.
Findings:
- Standard peripartal antibiotic prophylaxis does not prevent late-onset GBS infections.
- Despite reduced early-onset GBS incidence, late-onset cases continue to pose a threat.
- Neurological complications affect up to 40% of infants with late-onset GBS meningitis.
Implications:
- Maternal vaccination using multivalent conjugate vaccines is a potential new strategy for passive infant protection against GBS.
- Further research is crucial to evaluate the efficacy of GBS vaccines in preventing neonatal infections.
- Improved monitoring and therapeutic approaches are needed for GBS meningitis management.